StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Viridian Therapeutic (VRDN) PT Raised to $44 at RBC Capital
September 13, 2024 6:33 AM
RBC Capital analyst Gregory Renza raised the price target on Viridian Therapeutic (NASDAQ: VRDN) to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Form 424B5 Viridian Therapeutics,
September 13, 2024 6:09 AM
Form 8-K Viridian Therapeutics, For: Sep 11
September 12, 2024 5:26 PM
Viridian Therapeutics (VRDN) Prices Upsized 10.67M Share Offering at $18.75/sh
September 12, 2024 6:12 AM
Viridian Therapeutic (VRDN) PT Raised to $31 at Goldman Sachs
September 12, 2024 5:07 AM
Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock
September 11, 2024 11:25 PM
Viridian Therapeutic (VRDN) PT Raised to $38 at Needham
September 11, 2024 7:11 AM
H.C. Wainwright Reiterates Buy Rating on Viridian Therapeutic (VRDN)
September 11, 2024 6:37 AM
Viridian Therapeutic (VRDN) PT Raised to $22 at B.Riley
September 11, 2024 6:24 AM
